Related Experiment Videos

[A study on prolapse of the mitral valve in autopsy-proved papillary muscle dysfunction]

Journal of Cardiography
|August 1, 1984
PubMed

Insights

Pathologic evidence shows mitral valve prolapse occurs in 25% of patients with papillary muscle dysfunction (PMD). This morphologic prolapse differs from primary myxomatous degeneration seen in mitral valve prolapse (MVP).

Area of Science:

  • Cardiovascular Pathology
  • Cardiac Anatomy
  • Echocardiography

Background:

  • Echocardiography suggests a high incidence of mitral valve prolapse (MVP) in patients with papillary muscle dysfunction (PMD).
  • Pathologic evidence for MVP secondary to PMD has been lacking.
  • This study aimed to determine the incidence and morphology of mitral valve prolapse in pathologically confirmed PMD cases.

Observation:

  • 76 autopsy cases with PMD (aged >60) were examined for mitral valve morphology.
  • Morphologic mitral valve prolapse was defined as leaflet displacement into the left atrium.
  • Papillary muscle dysfunction was categorized into Type A (old MI), Type B (acute MI), and Type C (other causes).

Findings:

  • Morphologic mitral valve prolapse was identified in 19 of 76 cases (25%) with PMD.
  • No significant difference in prolapse incidence was observed across PMD types.
  • Prolapse predominantly occurred at the posteromedial commissure.
  • Echocardiography in 39 PMD cases identified MVP in only two cases with morphologic prolapse.

Implications:

  • Morphologic mitral valve prolapse secondary to PMD can be distinguished from primary myxomatous degeneration.
  • Pathologic findings provide crucial evidence for understanding MVP in the context of PMD.
  • This research aids in differentiating the etiology of mitral valve prolapse.

Related Concept Videos